Related Experiment Videos
Clindamycin and gentamicin in surgical infections
Abstract:
The combination of clindamycin phosphate and gentamicin sulfate in treating 53 patients with a variety of serious infections was studied. Initial cultures of specimens from 31 patients yielded both anaerobic and aerobic pathogens. Eleven cultures showed only anaerobic organisms and 11 showed only aerobes. Of patients treated with clindamycin and gentamicin and surgical intervention, 87.8% had bacteriologic cure. Clinical response was poor in only two cases. Two patients developed rash and one had diarrhea, but no reactions suggestive of pseudomembranous colitis were seen.
Insights
The combination of clindamycin and gentamicin effectively treated serious infections in 53 patients, achieving an 87.8% bacteriologic cure rate with minimal side effects.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Serious infections often involve polymicrobial flora, necessitating broad-spectrum antimicrobial therapy.
- Clindamycin phosphate and gentamicin sulfate are commonly used antibiotics with activity against anaerobic and aerobic bacteria, respectively.
Observation:
- A study evaluated the combination of clindamycin and gentamicin in 53 patients with serious infections.
- Initial cultures revealed a mix of anaerobic and aerobic pathogens in 31 patients, with 11 showing only anaerobes and 11 only aerobes.
Findings:
- The combination therapy, alongside surgical intervention, resulted in an 87.8% bacteriologic cure rate.
- Clinical response was poor in only two patients.
- Adverse events were infrequent, including rash (2 patients) and diarrhea (1 patient), with no cases of pseudomembranous colitis.
Implications:
- This antibiotic combination demonstrates significant efficacy in treating serious polymicrobial infections.
- The favorable safety profile suggests clindamycin and gentamicin can be a valuable therapeutic option.
- Further research could explore optimal dosing and duration for specific infection types.